- Home
- PLRZ vs GLMD Comparison
PLRZ vs GLMD Comparison
Compare PLRZ & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRZ
- GLMD
- Stock Information
- Founded
- PLRZ 2005
- GLMD 2000
- Country
- PLRZ Israel
- GLMD Israel
- Employees
- PLRZ N/A
- GLMD N/A
- Industry
- PLRZ
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- PLRZ
- GLMD Health Care
- Exchange
- PLRZ NYSE
- GLMD Nasdaq
- Market Cap
- PLRZ 3.7M
- GLMD 3.0M
- IPO Year
- PLRZ 2024
- GLMD 2014
- Fundamental
- Price
- PLRZ $0.69
- GLMD $1.83
- Analyst Decision
- PLRZ
- GLMD Hold
- Analyst Count
- PLRZ 0
- GLMD 1
- Target Price
- PLRZ N/A
- GLMD N/A
- AVG Volume (30 Days)
- PLRZ 3.0M
- GLMD 356.9K
- Earning Date
- PLRZ 02-15-2025
- GLMD 08-27-2025
- Dividend Yield
- PLRZ N/A
- GLMD N/A
- EPS Growth
- PLRZ N/A
- GLMD N/A
- EPS
- PLRZ N/A
- GLMD N/A
- Revenue
- PLRZ N/A
- GLMD N/A
- Revenue This Year
- PLRZ N/A
- GLMD N/A
- Revenue Next Year
- PLRZ N/A
- GLMD N/A
- P/E Ratio
- PLRZ N/A
- GLMD N/A
- Revenue Growth
- PLRZ N/A
- GLMD N/A
- 52 Week Low
- PLRZ $0.55
- GLMD $1.15
- 52 Week High
- PLRZ $1,200.00
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- PLRZ N/A
- GLMD 60.38
- Support Level
- PLRZ N/A
- GLMD $1.74
- Resistance Level
- PLRZ N/A
- GLMD $1.91
- Average True Range (ATR)
- PLRZ 0.00
- GLMD 0.12
- MACD
- PLRZ 0.00
- GLMD -0.00
- Stochastic Oscillator
- PLRZ 0.00
- GLMD 71.95
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.